Xeris Pharmaceuticals Inc reported $303.02M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acelrx Pharmaceuticals ACRX:US USD 48.31M 7.82M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Horizon Pharma HZNP:US USD 9.03B 174.39M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B